BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 30656528)

  • 1. The relevance of ERG immunoexpression intensity for prostatic adenocarcinoma in radical prostatectomy of 635 samples.
    Feitosa PMFA; Hirth CG; Silva-Fernandes IJL; Dornelas CA
    APMIS; 2023 Sep; 131(9):465-471. PubMed ID: 37439391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer.
    Zhao D; Cai L; Lu X; Liang X; Li J; Chen P; Ittmann M; Shang X; Jiang S; Li H; Meng C; Flores I; Song JH; Horner JW; Lan Z; Wu CJ; Li J; Chang Q; Chen KC; Wang G; Deng P; Spring DJ; Wang YA; DePinho RA
    Cancer Discov; 2020 Sep; 10(9):1374-1387. PubMed ID: 32385075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
    Washino S; Rider LC; Romero L; Jillson LK; Affandi T; Ohm AM; Lam ET; Reyland ME; Costello JC; Cramer SD
    Mol Cancer Res; 2019 Oct; 17(10):1985-1998. PubMed ID: 31300540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications.
    Singh N; Heemers HV
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37279256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Cancer Brain Metastasis: Review of a Rare Complication with Limited Treatment Options and Poor Prognosis.
    Rajeswaran K; Muzio K; Briones J; Lim-Fat MJ; Tseng CL; Smoragiewicz M; Detsky J; Emmenegger U
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular Meningiomas: Clinical-Pathological and Genetic Features of a Monocentric Series.
    Ammendola S; Simbolo M; Ciaparrone C; Rizzo PC; Caffo M; Pinna G; Sala F; Scarpa A; Barresi V
    Curr Oncol; 2022 Jan; 29(1):178-185. PubMed ID: 35049691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes.
    Jillson LK; Yette GA; Laajala TD; Tilley WD; Costello JC; Cramer SD
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34208794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic prostatic adenocarcinoma to the brain and spinal cord: a contemporary clinicopathologic analysis of 30 cases.
    Ogunbona OB; Goodman AL; Osunkoya AO
    Int J Clin Exp Pathol; 2021; 14(1):45-53. PubMed ID: 33532022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies.
    Berg KD
    Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERG protein expression as a biomarker of prostate cancer.
    Falzarano SM; Magi-Galluzzi C
    Biomark Med; 2013 Dec; 7(6):851-65. PubMed ID: 24266818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expression.
    Ormond DR; Kleinschmidt-DeMasters BK; Cavalcante D; Smith EE; Cramer SD; Lucia MS
    J Neurooncol; 2019 Apr; 142(2):319-325. PubMed ID: 30656528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer.
    Rodrigues LU; Rider L; Nieto C; Romero L; Karimpour-Fard A; Loda M; Lucia MS; Wu M; Shi L; Cimic A; Sirintrapun SJ; Nolley R; Pac C; Chen H; Peehl DM; Xu J; Liu W; Costello JC; Cramer SD
    Cancer Res; 2015 Mar; 75(6):1021-34. PubMed ID: 25770290
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Jillson LK; Rider LC; Rodrigues LU; Romero L; Karimpour-Fard A; Nieto C; Gillette C; Torkko K; Danis E; Smith EE; Nolley R; Peehl DM; Lucia MS; Costello JC; Cramer SD
    Mol Cancer Res; 2021 Jul; 19(7):1123-1136. PubMed ID: 33846123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ERG and PTEN protein expression in cribriform architecture prostate carcinomas.
    Downes MR; Satturwar S; Trudel D; van der Kwast TH
    Pathol Res Pract; 2017 Jan; 213(1):34-38. PubMed ID: 27913052
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.